Altre lingue Kyowa Kirin Co., Ltd. OTC Markets

Azioni

KYKOY

US50156R1077

Tempo differito OTC Markets Altri mercati azionari 15:50:18 16/07/2024			Variaz. 5gg	Var. 1 gen.
19,85 ^USD	+0,27%		0,00%	+22,18%

03/07	Kyowa Kirin riacquista azioni	MT
07/05	Utile di Kyowa Kirin in crescita del 15% nel 1° trimestre	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Kyowa Kirin Buys Back Shares	03/07
Tranche Update on Kyowa Kirin Co., Ltd.'s Equity Buyback Plan announced on February 7, 2024.	02/07
Kyowa Kirin : Announces Application for Additional Formulation of “LUMICEF® Subcutaneous Injection 210 mg Pen” in Japan	28/06
Kyowa Kirin Repurchases 3.3 Million Shares in May	05/06
Kyowa Kirin : Announces Approval for Partial Change of Approved Indication of G-Lasta® for the Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Autologous Blood Stem Cell Transplantation in Japan (243KB)	17/05
Kyowa Kirin : Transcript of Results Briefing Fiscal 2024 First Quarter (0B)	09/05
Kyowa Kirin's Profit Up 15% in Q1	07/05
Kyowa Kirin : Results Presentation Fiscal 2024 First Quarter (0B)	07/05
Orchard Therapeutics Co-founder and Chief Executive Officer Dr. Bobby Gaspar Named to Inaugural 2024 TIME100 Health List	06/05
Kyowa Kirin Buys Back Shares for 5.6 Billion Yen in April	06/05
BridgeBio Pharma Shares Decline After Q1 Financial Results	02/05
Kyowa Kirin to Present a Safety Meta-Analysis of NOURIANZ (istradefylline) and Other Parkinson's Disease Add-On Therapies	15/04
First Interim Analysis of PROSPER Study Details Patient-Reported Symptom Burden of Mycosis Fungoides and Sézary Syndrome	15/04
U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease	08/04
Kyowa Kirin Buys Back 4 Billion Yen Worth of Shares in March	03/04
Tranche Update on Kyowa Kirin Co., Ltd.'s Equity Buyback Plan announced on February 7, 2024.	02/04
Japanese Shares Slip into Red Amid Profit-Taking; Tokyo Inflation Eyed	25/03
Kyowa Kirin to Allocate Over 84,000 Treasury Shares as Director, Officer Compensation	25/03
Kyowa Kirin's gene therapy most expensive US drug with $4.3 million price tag	20/03
EEUU aprueba la primera terapia de genes para niños con una rara enfermedad hereditaria	18/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Kyowa Kirin Co., Ltd. OTC Markets

Azioni

KYKOY

US50156R1077

Altre lingue

Filtri